<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04580706</url>
  </required_header>
  <id_info>
    <org_study_id>2020-P2-097-01</org_study_id>
    <nct_id>NCT04580706</nct_id>
  </id_info>
  <brief_title>The Effect of Frailty and Other Geriatric Syndromes on the Prognosis of Elderly Patients With Acute Coronary Syndrome</brief_title>
  <official_title>The Effect of Frailty and Other Geriatric Syndromes on the Prognosis of Elderly Patients With Acute Coronary Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Friendship Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational clinical trail which will recruit 1000-1500 participants&#xD;
      over 65 years with frailty and acute coronary syndrome (ACS) in Beijing Friendship hospital.&#xD;
      The investigators will conduct frailty assessment (FRAIL scale, CFS, SPPB), comorbidities,&#xD;
      functional status (Barthel index, ADL, IADL), nutritional risk (MNA-SF), and then observe the&#xD;
      clinical outcomes of elderly ACS participants with frailty. Then, the investigators will&#xD;
      follow-up these participants separately in 1,3,6 and 12months, the anticipate follow-up time&#xD;
      is 1 year. According to the follow-up results, investigators will evaluate the impact of&#xD;
      frailty and other senile syndromes on the short-term and long-term prognosis of ACS, and&#xD;
      develop a scoring system for the prognosis evaluation of elderly ACS participants.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Year</target_duration>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>During hospitalization, assessed up to 2 months</time_frame>
    <description>All-cause death and cardiac death events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Adverse Cardiac and Cerebrovascular events</measure>
    <time_frame>During hospitalization, assessed up to 2 months</time_frame>
    <description>Major Adverse Cardiac and Cerebrovascular events including heart failure, cardiac shock, malignant arrhythmia, myocardial infarction, revascularization, and cerebral infarction</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Death</measure>
    <time_frame>1 year</time_frame>
    <description>All-cause death and cardiac death events</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Major Adverse Cardiac and Cerebrovascular events</measure>
    <time_frame>1 year</time_frame>
    <description>Major Adverse Cardiac and Cerebrovascular events including heart failure, cardiac shock, malignant arrhythmia, myocardial infarction, revascularization, and cerebral infarction</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>ACS</condition>
  <condition>Frail Elderly Syndrome</condition>
  <condition>Elderly Patient</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>this is an observational study with none intervention</intervention_name>
    <description>this is an observational study with none intervention</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This registry will include consecutive patients age â‰¥65 years admitted for ACS&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elderly participants over 65&#xD;
&#xD;
          -  Clinical diagnosis of acute coronary syndrome&#xD;
&#xD;
          -  Must be able to follow-up&#xD;
&#xD;
          -  Sign in the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Myocardial infarction caused by other acute disease&#xD;
&#xD;
          -  Mental disorders who cannot cooperate to complete the assessment&#xD;
&#xD;
          -  Severe liver dysfunction, kidney disease (CKD 5), end-stage malignant tumor&#xD;
&#xD;
          -  Totally disabled and bedridden&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sun Ying, MD</last_name>
    <phone>010-63137726</phone>
    <email>sunying@bfh.com.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Friendship hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>010</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sun Ying, MD</last_name>
      <phone>010-63137726</phone>
      <email>sunying@bfh.com.cn</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>September 11, 2020</study_first_submitted>
  <study_first_submitted_qc>October 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 8, 2020</study_first_posted>
  <last_update_submitted>October 7, 2020</last_update_submitted>
  <last_update_submitted_qc>October 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Friendship Hospital</investigator_affiliation>
    <investigator_full_name>Sun Ying</investigator_full_name>
    <investigator_title>Director of department geriatrics, Beijing Friendship Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Frailty</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

